Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

April 17, 2014

The analysis was conducted by Dr Benjamin Cowie and Ms Jennifer MacLachlan from the University of Melbourne and Melbourne Health, and was presented at The International Liver Congress in London earlier this month.

"Liver cancer is the fastest increasing cause of cancer deaths in Australia, increasing each year by 5 per cent, so by more than seventy people each year. In 2014 there was an estimated number of deaths of around 1,500 from liver cancer. The predominant cause is chronic viral Hepatitis," Dr Cowie said.

Hepatitis refers to the inflammation of the liver. Chronic infection with the blood-borne viruses Hepatitis B or Hepatitis C can result in scarring of the liver (cirrhosis) or potentially at a later stage – however these risks can be reduced through access to effective care and treatment.

Dr Cowie said additional resources were needed to prevent and treat Hepatitis B and C in order to address these imbalances in major preventable causes of human death.

"The release of the GBD 2010 results provides a unique opportunity to set global and local priorities for health, and address previous imbalances in addressing the major causes of preventable causes of human death, among which hepatitis B and C must clearly be counted."

"The Commonwealth Government has recently committed to funding initiatives to improve access to testing and treatment for people from priority populations living with B in Australia, which is a great step forward," he said.

"The Global Burden of Disease (GBD) estimated around 1.3 million people lost their lives to viral Hepatitis since 1990, which is comparable to the respective burdens of HIV/AIDS, tuberculosis and malaria," Dr Cowie concluded.

Explore further: Viral hepatitis more deadly than HIV in Europe

Related Stories

Viral hepatitis more deadly than HIV in Europe

April 11, 2014
Mortality from viral hepatitis is significantly higher than from HIV/AIDS across EU countries, according to results from The Global Burden of Disease Study 2010 (GBD 2010) which was announced for the first time today at the ...

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

March 17, 2014
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from ...

Coffee consumption reduces mortality risk from liver cirrhosis

April 2, 2014
New research reveals that consuming two or more cups of coffee each day reduces the risk of death from liver cirrhosis by 66%, specifically cirrhosis caused by non-viral hepatitis. Findings in Hepatology, a journal published ...

Hepatitis B screening proposed for all high-risk adults

February 11, 2014
(HealthDay)—Adults at high risk for hepatitis B should be screened for the viral infection, according to a draft recommendation from the U.S. Preventive Services Task Force.

Gene variants protect against relapse after treatment for hepatitis C

March 13, 2014
Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a gene, which explains why certain patients with chronic hepatitis C do not experience relapse after treatment. The discovery may contribute ...

New data reveals positive outcomes for hepatitis C transplant patients

April 11, 2014
New research announced at the International Liver Congress 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.